Sonnet BioTherapeutics (SONN) Competitors $1.25 -0.02 (-1.57%) Closing price 04/4/2025 04:00 PM EasternExtended Trading$1.24 -0.01 (-0.80%) As of 04/4/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SONN vs. MIRA, CMMB, BFRG, IMNN, ELEV, SLGL, CLDI, QNTM, MEIP, and CLRBShould you be buying Sonnet BioTherapeutics stock or one of its competitors? The main competitors of Sonnet BioTherapeutics include MIRA Pharmaceuticals (MIRA), Chemomab Therapeutics (CMMB), Bullfrog AI (BFRG), Imunon (IMNN), Elevation Oncology (ELEV), Sol-Gel Technologies (SLGL), Calidi Biotherapeutics (CLDI), Quantum Biopharma (QNTM), MEI Pharma (MEIP), and Cellectar Biosciences (CLRB). These companies are all part of the "pharmaceutical products" industry. Sonnet BioTherapeutics vs. MIRA Pharmaceuticals Chemomab Therapeutics Bullfrog AI Imunon Elevation Oncology Sol-Gel Technologies Calidi Biotherapeutics Quantum Biopharma MEI Pharma Cellectar Biosciences Sonnet BioTherapeutics (NASDAQ:SONN) and MIRA Pharmaceuticals (NASDAQ:MIRA) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings, media sentiment, valuation and community ranking. Which has more volatility and risk, SONN or MIRA? Sonnet BioTherapeutics has a beta of 0.58, indicating that its share price is 42% less volatile than the S&P 500. Comparatively, MIRA Pharmaceuticals has a beta of 2.05, indicating that its share price is 105% more volatile than the S&P 500. Which has stronger earnings & valuation, SONN or MIRA? Sonnet BioTherapeutics has higher revenue and earnings than MIRA Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSonnet BioTherapeutics$1M3.83-$7.44MN/AN/AMIRA PharmaceuticalsN/AN/A-$11.98M-$0.52-1.60 Is SONN or MIRA more profitable? MIRA Pharmaceuticals' return on equity of -337.44% beat Sonnet BioTherapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Sonnet BioTherapeuticsN/A -408.93% -174.13% MIRA Pharmaceuticals N/A -337.44%-280.58% Do analysts recommend SONN or MIRA? Sonnet BioTherapeutics presently has a consensus target price of $20.00, suggesting a potential upside of 1,500.00%. MIRA Pharmaceuticals has a consensus target price of $14.00, suggesting a potential upside of 1,577.85%. Given MIRA Pharmaceuticals' stronger consensus rating and higher probable upside, analysts plainly believe MIRA Pharmaceuticals is more favorable than Sonnet BioTherapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sonnet BioTherapeutics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00MIRA Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33 Does the MarketBeat Community prefer SONN or MIRA? Sonnet BioTherapeutics received 18 more outperform votes than MIRA Pharmaceuticals when rated by MarketBeat users. However, 100.00% of users gave MIRA Pharmaceuticals an outperform vote while only 84.00% of users gave Sonnet BioTherapeutics an outperform vote. CompanyUnderperformOutperformSonnet BioTherapeuticsOutperform Votes2184.00% Underperform Votes416.00%MIRA PharmaceuticalsOutperform Votes3100.00% Underperform VotesNo Votes Does the media refer more to SONN or MIRA? In the previous week, Sonnet BioTherapeutics had 4 more articles in the media than MIRA Pharmaceuticals. MarketBeat recorded 12 mentions for Sonnet BioTherapeutics and 8 mentions for MIRA Pharmaceuticals. MIRA Pharmaceuticals' average media sentiment score of 0.37 beat Sonnet BioTherapeutics' score of -0.33 indicating that MIRA Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sonnet BioTherapeutics 0 Very Positive mention(s) 1 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 3 Very Negative mention(s) Neutral MIRA Pharmaceuticals 0 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do institutionals and insiders believe in SONN or MIRA? 9.4% of Sonnet BioTherapeutics shares are owned by institutional investors. Comparatively, 35.2% of MIRA Pharmaceuticals shares are owned by institutional investors. 2.0% of Sonnet BioTherapeutics shares are owned by insiders. Comparatively, 6.7% of MIRA Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. SummaryMIRA Pharmaceuticals beats Sonnet BioTherapeutics on 10 of the 15 factors compared between the two stocks. Remove Ads Get Sonnet BioTherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SONN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SONN vs. The Competition Export to ExcelMetricSonnet BioTherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.83M$6.35B$5.26B$7.12BDividend YieldN/A2.85%4.89%4.08%P/E RatioN/A6.8321.3817.51Price / Sales3.83187.43355.0688.78Price / CashN/A65.6738.1834.64Price / Book0.955.576.233.79Net Income-$7.44M$141.89M$3.21B$247.48M7 Day Performance-4.58%-11.51%-8.47%-6.79%1 Month Performance-14.38%-16.59%-4.87%-11.53%1 Year Performance-37.50%-18.14%2.54%-7.82% Sonnet BioTherapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SONNSonnet BioTherapeutics2.0324 of 5 stars$1.25-1.6%$20.00+1,500.0%-36.9%$3.83M$1M0.0010News CoverageGap UpMIRAMIRA Pharmaceuticals1.7579 of 5 stars$0.98-7.5%$14.00+1,328.6%-18.2%$16.23MN/A-1.752Earnings ReportUpcoming EarningsAnalyst RevisionNews CoverageGap DownCMMBChemomab Therapeutics3.3321 of 5 stars$1.09-3.5%$9.00+725.7%+32.9%$15.65MN/A-1.0920Gap DownBFRGBullfrog AI0.8801 of 5 stars$1.65-2.9%N/A-60.8%$15.54M$60,000.00-1.944News CoverageGap DownIMNNImunon1.7413 of 5 stars$1.05-3.7%$21.50+1,947.6%-30.9%$15.35M$500,000.00-0.5630ELEVElevation Oncology1.9583 of 5 stars$0.26-0.3%$3.39+1,206.7%-95.1%$15.34MN/A-0.3240Gap DownSLGLSol-Gel Technologies2.5177 of 5 stars$0.55-0.4%$5.00+812.4%-53.4%$15.27M$11.71M-1.6150CLDICalidi Biotherapeutics1.4709 of 5 stars$0.57-12.9%$15.00+2,549.2%N/A$14.98M$50,000.000.0038Gap DownQNTMQuantum BiopharmaN/A$7.71-9.9%N/AN/A$14.80MN/A-0.50N/AEarnings ReportGap DownMEIPMEI Pharma3.7046 of 5 stars$2.19-6.8%$7.00+219.6%-49.4%$14.59M$65.30M-0.38100Gap DownCLRBCellectar Biosciences1.4138 of 5 stars$0.32-5.8%$12.50+3,864.5%-92.9%$14.53MN/A-0.1810Analyst Forecast Remove Ads Related Companies and Tools Related Companies MIRA Pharmaceuticals Competitors Chemomab Therapeutics Competitors Bullfrog AI Competitors Imunon Competitors Elevation Oncology Competitors Sol-Gel Technologies Competitors Calidi Biotherapeutics Competitors Quantum Biopharma Competitors MEI Pharma Competitors Cellectar Biosciences Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SONN) was last updated on 4/5/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sonnet BioTherapeutics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sonnet BioTherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SONN Stock Free SONN Stock Alerts